We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

37 hedge funds and large institutions have $9.16M invested in Lumos Pharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

6% more funds holding

Funds holding: 35 → 37 (+2)

60% less capital invested

Capital invested by funds: $23M → $9.16M (-$13.8M)

Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
7
Closed
2
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
-$22K

Top Buyers

Rank Fund Capital Flow
1
JFG
Jefferies Financial Group
New York
+$789K
2
SC
Shay Capital
New York
+$327K
3
Millennium Management
Millennium Management
New York
+$131K
4
Citadel Advisors
Citadel Advisors
Florida
+$117K
5
VF
Virtu Financial
New York
+$69K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$749K
2
OM
Opaleye Management
Massachusetts
-$412K
3
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$295K
4
KPF
K2 Principal Fund
Ontario, Canada
-$262K
5
Renaissance Technologies
Renaissance Technologies
New York
-$114K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$7.34K +$8.44K +1,291 +174%
WFA
27
West Financial Advisors
Iowa
$2.83K – – –
Morgan Stanley
28
Morgan Stanley
New York
$1.24K – – –
Group One Trading
29
Group One Trading
Illinois
$542 – – –
Northwestern Mutual Wealth Management
30
Northwestern Mutual Wealth Management
Wisconsin
$264 – – –
SSC
31
Syverson Strege & Co
Iowa
$79 – – –
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$75 – – –
PAG
33
Private Advisor Group
New Jersey
$72 +$19.6K +3,000 +18%
Bank of America
34
Bank of America
North Carolina
$44 +$78 +12 New
GRP
35
Global Retirement Partners
California
$40 – – –
LOIP
36
Live Oak Investment Partners
Texas
$39 – – –
OM
37
Opaleye Management
Massachusetts
– -$412K -46,576 Closed
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$295K -33,367 Closed
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
– -$1.32K -202 -80%
JP Morgan Chase
40
JP Morgan Chase
New York
– -$59 -9 -31%
1
2

LUMO Hedge Fund Activity: Q4 2022 in Review

37 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2022, worth a combined $9.16M — down 60% from $23M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new LUMO positions and 2 closed out — a net gain of 5 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Jefferies Financial Group, opening a new position worth an estimated $789K. The largest seller was Goldman Sachs, cutting an estimated $749K.

  • 37 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2022, up from 35 in Q3 2022.
  • Funds reported $9.16M of Lumos Pharma, Inc. Common Stock stock for Q4 2022, down 60% quarter-over-quarter.
  • 7 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2022 and 2 closed out, a net change of +5 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q4 2022 was Jefferies Financial Group, an estimated $789K added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q4 2022 was Goldman Sachs, an estimated $749K sold.

Based on aggregated 13F filings for Q4 2022.